Trials / Conditions / Endocarditis, Bacterial

Endocarditis, Bacterial

17 registered clinical trials studyying Endocarditis, Bacterial — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Terminated	Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis Treatment NCT06563609	Johannes Grand	N/A
Recruiting	Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis NCT06870409	University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)	Phase 3
Recruiting	New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System NCT06250985	Rigshospitalet, Denmark	Phase 3
Not Yet Recruiting	Effectiveness of Antibiotic Prophylaxis of Infective Endocarditis for Invasive Dental Procedures in Patients W NCT05613933	University Hospital, Bordeaux	N/A
Unknown	T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis NCT05644990	Charles University, Czech Republic	—
Unknown	Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly NCT05522764	Fondation Hôpital Saint-Joseph	—
Unknown	Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort Study NCT05152225	the Jeunes en Neuroradiologie Interventionnelle (JENI) research group	—
Completed	Anemia in Patients With Endocarditis NCT04840225	Rigshospitalet, Denmark	—
Terminated	Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis NCT04222257	Carmen Olmos Blanco	Phase 4
Recruiting	Barts Endocarditis Research Registry NCT06434012	Queen Mary University of London	—
Completed	Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis NCT03048643	Laura Fanucchi	N/A
Recruiting	Fosfomycin I.v. for Treatment of Severely Infected Patients NCT02979951	Infectopharm Arzneimittel GmbH	—
Completed	Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients NCT03306225	Fondation Hôpital Saint-Joseph	—
Terminated	Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA B NCT00695903	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	How to Improve Diagnosis in Infective Endocarditis NCT00524212	University of Aarhus	—
Terminated	Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis. NCT00401960	Weill Medical College of Cornell University	Phase 4
Completed	IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis NCT00144885	Assistance Publique - Hôpitaux de Paris	N/A